PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lung Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.\', \'National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.\', \'Lung Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom; ICR NIHR Biomedical Research Centre.\', \'Lung Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Thoracic Oncology, Institute of Cancer Research, London, United Kingdom. Electronic address: sanjay.popat@rmh.nhs.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2468-2942(20)30096-410.1016/j.ctarc.2020.100261
?:doi
?:hasPublicationType
?:journal
  • Cancer treatment and research communications
is ?:pmid of
?:pmid
?:pmid
  • 33310368
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.25
?:rankingScore_hIndex
  • 5
is ?:relation_isRelatedTo_publication of
?:title
  • Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all